Cargando…

Natural Killer Cells in Healthy and Diseased Subjects

Detalles Bibliográficos
Autores principales:	Biassoni, Roberto, Coligan, John E., Moretta, Lorenzo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2011
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3166578/ https://www.ncbi.nlm.nih.gov/pubmed/21904444 http://dx.doi.org/10.1155/2011/795251

Ejemplares similares

Identification and Molecular Cloning of P75/Airm1, a Novel Member of the Sialoadhesin Family That Functions as an Inhibitory Receptor in Human Natural Killer Cells
por: Falco, Michela, et al.
Publicado: (1999)

NKp44, A Triggering Receptor Involved in Tumor Cell Lysis by Activated Human Natural Killer Cells, Is a Novel Member of the Immunoglobulin Superfamily
por: Cantoni, Claudia, et al.
Publicado: (1999)

Identification and Molecular Characterization of Nkp30, a Novel Triggering Receptor Involved in Natural Cytotoxicity Mediated by Human Natural Killer Cells
por: Pende, Daniela, et al.
Publicado: (1999)

Gntb-A, a Novel Sh2d1a-Associated Surface Molecule Contributing to the Inability of Natural Killer Cells to Kill Epstein-Barr Virus–Infected B Cells in X-Linked Lymphoproliferative Disease
por: Bottino, Cristina, et al.
Publicado: (2001)

Transplantation and innate immunity: the lesson of natural killer cells
por: Bertaina, Alice, et al.
Publicado: (2009)

X-Linked Lymphoproliferative Disease: 2b4 Molecules Displaying Inhibitory Rather than Activating Function Are Responsible for the Inability of Natural Killer Cells to Kill Epstein-Barr Virus–Infected Cells
por: Parolini, Silvia, et al.
Publicado: (2000)

Dendritic Cell Editing by Activated Natural Killer Cells Results in a More Protective Cancer-Specific Immune Response
por: Morandi, Barbara, et al.
Publicado: (2012)

NKG2A Complexed with CD94 Defines a Novel Inhibitory Natural Killer Cell Receptor
por: Brooks, Andrew G., et al.
Publicado: (1997)

Natural Killer Cells and Immunotherapy
por: Noh, Ji-Yoon, et al.
Publicado: (2023)

Molecular Cloning of NKp46: A Novel Member of the Immunoglobulin Superfamily Involved in Triggering of Natural Cytotoxicity
por: Pessino, Anna, et al.
Publicado: (1998)

p46, a Novel Natural Killer Cell–specific Surface Molecule That Mediates Cell Activation
por: Sivori, Simona, et al.
Publicado: (1997)

Natural Killer Cells and Neuroblastoma: Tumor Recognition, Escape Mechanisms, and Possible Novel Immunotherapeutic Approaches
por: Bottino, Cristina, et al.
Publicado: (2014)

Natural killer cells in tumor immunotherapy
por: Wang, Dongyao, et al.
Publicado: (2023)

Natural killer T cells
por: Kanellopoulos, Jean
Publicado: (2015)

The Immune Checkpoint PD-1 in Natural Killer Cells: Expression, Function and Targeting in Tumour Immunotherapy
por: Quatrini, Linda, et al.
Publicado: (2020)

Natural killer cells: From surface receptors to the cure of high‐risk leukemia (Ceppellini Lecture)
por: Falco, Michela, et al.
Publicado: (2019)

The Role of Natural Killer Cells in Nonalcoholic Steatohepatitis: An Ongoing Debate
por: Jiang, Xiaojun, et al.
Publicado: (2021)

Special Issue “New Developments in Natural Killer Cells for Immunotherapy”
por: Zimmer, Jacques, et al.
Publicado: (2023)

Recognition of Human Histocompatibility Leukocyte Antigen (HLA)-E Complexed with HLA Class I Signal Sequence–derived Peptides by CD94/NKG2 Confers Protection from Natural Killer Cell–mediated Lysis
por: Borrego, Francisco, et al.
Publicado: (1998)

Inhibitory checkpoints in human natural killer cells: IUPHAR Review 28
por: Mariotti, F.R., et al.
Publicado: (2020)

An actin cytoskeletal barrier inhibits lytic granule release from natural killer cells in patients with Chediak-Higashi syndrome
por: Gil-Krzewska, Aleksandra, et al.
Publicado: (2018)

Susceptibility of Human Melanoma Cells to Autologous Natural Killer (NK) Cell Killing: HLA-Related Effector Mechanisms and Role of Unlicensed NK Cells
por: Carrega, Paolo, et al.
Publicado: (2009)

Human Dendritic Cells Activate Resting Natural Killer (NK) Cells and Are Recognized via the NKp30 Receptor by Activated NK Cells
por: Ferlazzo, Guido, et al.
Publicado: (2002)

CD56 Is a Pathogen Recognition Receptor on Human Natural Killer Cells
por: Ziegler, Sabrina, et al.
Publicado: (2017)

Natural Killer Cells and Thyroid Diseases
por: Lee, Eun Kyung, et al.
Publicado: (2019)

NKp44, a Novel Triggering Surface Molecule Specifically Expressed by Activated Natural Killer Cells, Is Involved in Non–Major Histocompatibility Complex–restricted Tumor Cell Lysis
por: Vitale, Massimo, et al.
Publicado: (1998)

Natural killer cells and natural killer T cells in Lyme arthritis
por: Katchar, Kia, et al.
Publicado: (2013)

Late Development of FcεRγ(neg) Adaptive Natural Killer Cells Upon Human Cytomegalovirus Reactivation in Umbilical Cord Blood Transplantation Recipients
por: Muccio, Letizia, et al.
Publicado: (2018)

Natural killer cells for cancer immunotherapy: a new CAR is catching up
Publicado: (2019)

NKp44-NKp44 Ligand Interactions in the Regulation of Natural Killer Cells and Other Innate Lymphoid Cells in Humans
por: Parodi, Monica, et al.
Publicado: (2019)

Deciphering the biology of NKG2C+ natural killer cells
por: Rölle, Alexander
Publicado: (2015)

Do tumor cells escape from natural killer cell cytotoxicity by mimicking dendritic cells?
por: Wurzer, Hannah, et al.
Publicado: (2019)

An Anti-inflammatory microRNA Signature Distinguishes Group 3 Innate Lymphoid Cells From Natural Killer Cells in Human Decidua
por: Pelosi, Andrea, et al.
Publicado: (2020)

Natural Killer Cells and Their Implications in Immune Response Diversification in Clinical Pathology and Neoplastic Processes
por: Legaz, Isabel, et al.
Publicado: (2023)

Primitive Neuroectodermal Tumor in an Ovarian Cystic Teratoma: Natural Killer and Neuroblastoma Cell Analysis
por: Tabellini, Giovanna, et al.
Publicado: (2014)

Roles of Natural Killer T Cells and Natural Killer Cells in Kidney Injury
por: Uchida, Takahiro, et al.
Publicado: (2019)

Natural killer cells in the brain tumor microenvironment: Defining a new era in neuro-oncology
por: Fares, Jawad, et al.
Publicado: (2019)

Natural killer cell deficiency experiences higher risk of sepsis after critical intracerebral hemorrhage
por: Feng, Yu, et al.
Publicado: (2021)

Ex Vivo Expansion of Highly Cytotoxic Natural Killer Cells Using Optimal Culture Medium
por: Kim, Seokho
Publicado: (2022)

Natural killer and lymphokine activated killer cell functions in Hodgkin's disease.
por: Rajaram, N., et al.
Publicado: (1990)

Cannot write session to /tmp/vufind_sessions/sess_ag7gq6n5k9ca0pots5dnt5ovta